---
title: "HHS said to be eyeing two new FDA deputy commissioners for technology and drugs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296945299.md"
description: "HHS plans to create two new FDA deputy commissioner roles: one for technology/AI and another for drugs, aiming to increase influence over the agency. Following CNBC's report, AI healthcare stocks like Twist Bioscience and Tempus AI rose. Jared Seehafer is a leading contender for the tech role, while both appointees will report to nominee Heidi Overton. No formal announcements have been made yet."
datetime: "2026-08-25T18:01:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296945299.md)
  - [en](https://longbridge.com/en/news/296945299.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296945299.md)
generator: "portal-rs"
---

# HHS said to be eyeing two new FDA deputy commissioners for technology and drugs


### Related Stocks

- [TWST.US](https://longbridge.com/en/quote/TWST.US.md)
- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)
- [TEMT.US](https://longbridge.com/en/quote/TEMT.US.md)

## Related News & Research

- [Tempus AI director Nadja West sells 3,000 shares worth $207,000](https://longbridge.com/en/news/297693362.md)
- [Carterra supports AI‑designed protein study with HT-SPR platforms](https://longbridge.com/en/news/298022490.md)
- [Why the AI boom has become an election problem](https://longbridge.com/en/news/297766132.md)
- [Parents learned AI was in their kids' classrooms. Then they took it to Mamdani's office.](https://longbridge.com/en/news/298031438.md)
- [Berkshire just revealed its playbook for AI’s next bottleneck](https://longbridge.com/en/news/297894696.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**